December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
December 19, 2022 December 19, 2022Categories News StoriesBlinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL
December 15, 2022 December 15, 2022Categories News StoriesStudy E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)
December 14, 2022 December 14, 2022Categories News StoriesBlinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)
December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesHealthDay News informs the public of the 12-year TAILORx results
December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
December 11, 2022 December 11, 2022Categories Press ReleasesPress Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)
December 6, 2022 December 6, 2022Categories Press ReleasesPress Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
